{"entity":{"type":"insider","cik":"0001341508","url":"/insider/0001341508","json_url":"/insider/0001341508.json","name":"LVP III Associates, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":2,"first":"2013-07-23","last":"2018-08-21","span_basis":"filed_date"},"name_variants":[{"name":"LVP III Associates, L.P.","source":"filing","n_filings":2,"first_seen":"2013-07-23","last_seen":"2018-08-21"}],"transactions":[{"id":6079418,"accession":"0001209191-18-047750","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-047750","line_url":"/filing/0001209191-18-047750","is_derivative":false,"issuer_cik":"0001201886","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001201886","owner_cik":null,"owner_name":"LATTERELL PATRICK F; LVP GP III, LLC; LVP LIFE SCIENCE VENTURES III L.P.; LVP III Associates, L.P.; LVPMC, LLC; LVP III Partners LP","owner_display_name":"LATTERELL PATRICK F","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":2.35,"price_display":"2.35","price_state":"stated","total_value":1175000.0,"total_display":"1,175,000.00","total_whole":"1,175,000","shares_owned_after":1937983.0,"shares_owned_after_display":"1,937,983","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-20","filed_date":"2018-08-21","scope":"insider","n_lines":3},{"id":4481660,"accession":"0001181431-13-041163","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001181431-13-041163","line_url":"/filing/0001181431-13-041163","is_derivative":false,"issuer_cik":"0001165583","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001165583","owner_cik":null,"owner_name":"LVP GP I, LLC; LATTERELL PATRICK F; LVP Life Science Ventures I, L.P.; LVP GP III, LLC; LVP III Associates, L.P.; LVP Life Science Ventures II, L.P.; LVP III Partners LP; LVPMC, LLC; LVP GP II, LLC; LVP LIFE SCIENCE VENTURES III L.P.","owner_display_name":"LVP GP I, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":88235.0,"shares_display":"88,235","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":1499995.0,"total_display":"1,499,995.00","total_whole":"1,499,995","shares_owned_after":1348212.0,"shares_owned_after_display":"1,348,212","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-23","filed_date":"2013-07-23","scope":"insider","n_lines":5}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001403708","name":"Evoke Pharma Inc","url":"/issuer/0001403708","role":"Ten percent owner","n_filings":1,"first_seen":"2018-08-21","last_seen":"2018-08-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001302573","name":"OncoMed Pharmaceuticals Inc","url":"/issuer/0001302573","role":"Ten percent owner","n_filings":1,"first_seen":"2013-07-23","last_seen":"2013-07-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001341508","retrieved_at":"2026-08-23T14:04:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}